Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zona pellucida-like domain-containing protein 1 (ZPLD1, also known as cupulin) is a highly conserved, secreted glycoprotein characterized by the presence of a zona pellucida-like domain, a structural motif central to its role in matrix assembly[2][4][5]. In vertebrates, ZPLD1 is a major constituent of the cupula, a gelatinous structure that overlays the crista ampullaris in the semicircular canals of the inner ear, critical for detecting rotational head movements and maintaining balance[2][4]. In mice, loss-of-function mutations in Zpld1 result in pronounced vestibular deficits without affecting cochlear or otolithic organ functions, implicating ZPLD1 as an essential structural component of the vestibular apparatus[2]. While its homologs and family share roles in various extracellular matrices, there are no current reports of ZPLD1 acting as a disease gene or as a direct clinical target in humans[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zona pellucida-like domain-containing protein 1 (ZPLD1).